Financial reports
10-Q
2017 Q3
Quarterly report
4 Mar 19
10-Q
2017 Q2
Quarterly report
18 Dec 18
10-Q
2017 Q1
Quarterly report
17 Aug 18
10-K
2016 FY
Annual report
1 Mar 18
10-Q
2016 Q3
Quarterly report
15 Mar 17
10-Q
2016 Q2
Quarterly report
9 Mar 17
Current reports
8-K
Departure of Directors or Certain Officers
16 Sep 19
8-K
Changes in Registrant's Certifying Accountant
8 Jun 18
8-K
Entry into a Material Definitive Agreement
4 May 18
8-K/A
Entry into a Material Definitive Agreement
25 May 17
8-K
Entry into a Material Definitive Agreement
22 May 17
8-K
Changes in Registrant's Certifying Accountant
16 May 17
8-K
Entry into a Material Definitive Agreement
1 May 17
8-K
Entry into a Material Definitive Agreement
19 Dec 16
8-K
Unregistered Sales of Equity Securities
1 Jun 15
8-K
Eastgate Biotech Corp. Names New President
21 Jan 15
Registration and prospectus
15-12G
Securities registration termination
2 Aug 19
S-1/A
IPO registration (amended)
22 Jul 14
S-1
IPO registration
1 Jul 14
S-8
Registration of securities for employees
16 Jun 14
S-1/A
IPO registration (amended)
26 Sep 13
S-1/A
IPO registration (amended)
5 Sep 13
S-1/A
IPO registration (amended)
29 Jul 13
S-1/A
IPO registration (amended)
27 Jun 13
S-1/A
IPO registration (amended)
14 May 13
S-1/A
IPO registration (amended)
29 Jan 13
Other
CT ORDER
Confidential treatment order
24 Nov 14
EFFECT
Notice of effectiveness
11 Aug 14
CORRESP
Correspondence with SEC
8 Aug 14
UPLOAD
Letter from SEC
15 Jul 14
UPLOAD
Letter from SEC
28 Oct 13
EFFECT
Notice of effectiveness
16 Oct 13
CORRESP
Correspondence with SEC
10 Oct 13
UPLOAD
Letter from SEC
18 Sep 13
UPLOAD
Letter from SEC
8 Aug 13
CORRESP
Correspondence with SEC
7 Aug 13